STAAR Surgical Stock Jumps 18% on Q1 Sales Beat

Stock Surges on Preliminary Sales Beat

STAAR Surgical Company (NASDAQ:STAA) shares rose 18% in after-hours trading following the announcement of preliminary first-quarter net sales that significantly surpassed analyst expectations. The vision correction company projects sales will exceed $90 million for the quarter.

Market Performance Overview

The company announced that net sales for the first quarter ending April 3, 2026, are expected to be over $90 million, well above the Wall Street consensus of $67.2 million. This figure represents more than double the $42.6 million in net sales reported in the same quarter of 2025. The strong performance was largely driven by China, its biggest market, along with continued double-digit growth in the Americas.

The company noted that sales in the first quarter of 2025 were affected by minimal shipments to China as distributors cleared excess inventory. This inventory level has now returned to the company's targeted range.

Economic and Regional Impact

Despite the overall positive results, STAAR Surgical faced headwinds in certain regions. Net sales in the Middle East and parts of the EMEA and APAC regions declined due to geopolitical and macroeconomic challenges. The company warned that persistent adverse conditions in these areas could continue to negatively affect sales growth.

Summary and Outlook

Deborah Andrews, Interim Co-CEO and CFO, stated that the results align with the company's objectives of Revenue Growth and Profit Expansion. However, STAAR Surgical reiterated that it is not providing forward revenue or earnings guidance. The announced figures are preliminary, unaudited, and subject to adjustment, with the full financial report expected in early May.

FAQ

Q: Why did STAAR Surgical's stock price increase?
A: The stock rose 18% after the company announced preliminary Q1 net sales are expected to exceed $90 million, significantly beating analyst estimates of $67.2 million.

Q: Which market was the main driver of STAAR's sales growth?
A: China, the company's largest market, accounted for the majority of the sales increase, while the Americas also showed strong double-digit growth.

Q: When will STAAR Surgical report its full financial results?
A: The company expects to report its full, audited first-quarter financial results in early May.

Source: Investing.com